Enrich Biosystems

Branford, CT · Founded 2018 · Privately Held (backing)

Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level. Enrich Biosystems is based in Branford, CT and was founded in 2018. Its last reported valuation was $11.9 million in May 2022. It has raised $8.6 million across 3 recorded rounds; the latest was a $1.4 million debt round in Nov 2025.

Last reported valuation
$11.9M
Oct 2026
Priced at
—
Total raised
$8.6M
Last round
Debt
Nov 2025

Who backs Enrich Biosystems?

15 investors
InvestorType
MedTech InnovatorOther
National Institutes of HealthOther
Connecticut InnovationsVenture capital
Decent CapitalFamily office
BioTools InnovatorOther
Accelerator for Biosciences in Connecticut—
Aimers Venture Partners—
Boston Harbor Angels—
Elm Street Ventures—
Massachusetts Biomedical Initiatives—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Enrich Biosystems investors

15 investors are on record for Enrich Biosystems, including MedTech Innovator, National Institutes of Health, Connecticut Innovations and Decent Capital. The debt round in Nov 2025 drew 4 investors.

Free account
More of Enrich Biosystems with a free account
  • ·The complete investor list: 15 names
  • ·Watch Enrich Biosystems: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Enrich Biosystems. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View